HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johnny Vlaminck Selected Research

Johnny Vlaminck Research Topics

Disease

18Infections
10/2021 - 06/2010
4Filarial Elephantiasis (Lymphatic Filariasis)
06/2021 - 03/2016
4Ascariasis
12/2020 - 10/2011
2Helminthiasis (Helminthiases)
11/2020 - 01/2019
2Trichuriasis
01/2020 - 01/2020
1Reinfection
01/2022
1Loiasis
01/2020
1Intestinal Volvulus (Volvulus)
01/2019
1Filariasis
01/2016
1Inflammation (Inflammations)
06/2010

Drug/Important Bio-Agent (IBA)

8Pharmaceutical PreparationsIBA
01/2022 - 01/2018
6Albendazole (Albenza)FDA Link
06/2021 - 03/2016
3AnthelminticsIBA
01/2020 - 03/2015
3AntigensIBA
01/2019 - 06/2010
2Ivermectin (Mectizan)FDA Link
01/2020 - 11/2015
2benzimidazoleIBA
01/2020 - 01/2020
2Diethylcarbamazine (Hetrazan)FDA Link
01/2020 - 03/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2020 - 01/2019
1LipidsIBA
12/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1TabletsIBA
01/2020
1Levamisole (Decaris)FDA Link
04/2019
1AntibodiesIBA
01/2019
1EpitopesIBA
01/2019
1Peptides (Polypeptides)IBA
01/2019
1EnzymesIBA
01/2016
1ImmunosorbentsIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
03/2015
1Quil AIBA
03/2015
1VaccinesIBA
10/2011
1AcidsIBA
06/2010

Therapy/Procedure

4Mass Drug Administration
06/2021 - 01/2018
2Drug Therapy (Chemotherapy)
11/2020 - 01/2020